Mercer Global Advisors Inc. ADV lessened its stake in shares of UnitedHealth Group Inc (NYSE:UNH) by 2.2% during the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 49,778 shares of the healthcare conglomerate’s stock after selling 1,137 shares during the quarter. Mercer Global Advisors Inc. ADV’s holdings in UnitedHealth Group were worth $12,414,000 at the end of the most recent quarter.
A number of other large investors also recently added to or reduced their stakes in the stock. Capital World Investors raised its holdings in UnitedHealth Group by 7.2% during the 4th quarter. Capital World Investors now owns 47,932,997 shares of the healthcare conglomerate’s stock valued at $14,091,342,000 after buying an additional 3,219,554 shares during the period. State Street Corp raised its holdings in UnitedHealth Group by 0.5% during the 1st quarter. State Street Corp now owns 46,003,796 shares of the healthcare conglomerate’s stock valued at $11,472,427,000 after buying an additional 212,240 shares during the period. Wellington Management Group LLP raised its holdings in UnitedHealth Group by 0.4% during the 1st quarter. Wellington Management Group LLP now owns 32,775,678 shares of the healthcare conglomerate’s stock valued at $8,173,598,000 after buying an additional 136,814 shares during the period. Capital Research Global Investors raised its holdings in UnitedHealth Group by 32.1% during the 4th quarter. Capital Research Global Investors now owns 29,851,016 shares of the healthcare conglomerate’s stock valued at $8,775,602,000 after buying an additional 7,261,158 shares during the period. Finally, Capital International Investors raised its holdings in UnitedHealth Group by 4.4% during the 4th quarter. Capital International Investors now owns 25,843,701 shares of the healthcare conglomerate’s stock valued at $7,597,531,000 after buying an additional 1,082,141 shares during the period. Institutional investors own 86.59% of the company’s stock.
UNH stock traded up $1.01 during trading on Friday, reaching $291.24. 5,172,840 shares of the company traded hands, compared to its average volume of 4,047,542. UnitedHealth Group Inc has a 12 month low of $187.72 and a 12 month high of $315.84. The business has a 50 day simple moving average of $293.73 and a 200 day simple moving average of $281.69. The company has a market capitalization of $276.21 billion, a price-to-earnings ratio of 20.38, a price-to-earnings-growth ratio of 1.43 and a beta of 0.72. The company has a debt-to-equity ratio of 0.60, a quick ratio of 0.75 and a current ratio of 0.75.
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 30th. Investors of record on Monday, June 22nd will be given a dividend of $1.25 per share. The ex-dividend date is Friday, June 19th. This represents a $5.00 dividend on an annualized basis and a yield of 1.72%. This is an increase from UnitedHealth Group’s previous quarterly dividend of $1.08. UnitedHealth Group’s dividend payout ratio (DPR) is presently 28.59%.
Several research firms recently weighed in on UNH. Morgan Stanley increased their price target on UnitedHealth Group from $289.00 to $371.00 and gave the company an “overweight” rating in a report on Thursday, April 30th. Barclays reiterated a “buy” rating and issued a $322.00 target price on shares of UnitedHealth Group in a research note on Sunday, March 29th. Deutsche Bank reduced their target price on UnitedHealth Group from $308.00 to $293.00 and set a “buy” rating on the stock in a research note on Thursday, April 16th. Citigroup reduced their target price on UnitedHealth Group from $346.00 to $339.00 and set a “buy” rating on the stock in a research note on Friday, April 24th. Finally, SunTrust Banks increased their target price on UnitedHealth Group from $340.00 to $360.00 and gave the stock a “buy” rating in a research note on Thursday, May 21st. Four investment analysts have rated the stock with a hold rating and twenty-one have issued a buy rating to the company’s stock. The stock has an average rating of “Buy” and a consensus target price of $323.13.
In related news, Director Stephen J. Hemsley sold 45,637 shares of the firm’s stock in a transaction dated Monday, May 11th. The stock was sold at an average price of $289.11, for a total transaction of $13,194,113.07. Following the sale, the director now owns 1,013,122 shares of the company’s stock, valued at $292,903,701.42. The sale was disclosed in a filing with the SEC, which is available through the SEC website. 0.80% of the stock is owned by company insiders.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Recommended Story: How to calculate the intrinsic value of a stock
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.